Coldstream Capital Management Inc Vir Biotechnology, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 89 shares of VIR stock, worth $547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89Holding current value
$547% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
248Shares Held
91.9MCall Options Held
1.32MPut Options Held
195K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$103 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$78.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$35.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$19.8 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $816M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...